KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 83 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,157,982 | -83.8% | 689,451 | -63.5% | 0.57% | -83.8% |
| Q4 2022 | $13,301,735 | -12.4% | 1,889,451 | +7.2% | 3.54% | -13.2% |
| Q3 2022 | $15,178,000 | -0.3% | 1,762,793 | -9.2% | 4.08% | -29.8% |
| Q2 2022 | $15,228,000 | +191.2% | 1,940,793 | +516.9% | 5.82% | +161.5% |
| Q1 2022 | $5,229,000 | +14.9% | 314,612 | +15.6% | 2.22% | +47.2% |
| Q4 2021 | $4,552,000 | +602.5% | 272,250 | +263.0% | 1.51% | +699.5% |
| Q3 2021 | $648,000 | -18.6% | 75,000 | -48.9% | 0.19% | +2.2% |
| Q2 2021 | $796,000 | -23.3% | 146,680 | -15.8% | 0.18% | -11.1% |
| Q1 2021 | $1,038,000 | +47.2% | 174,169 | +29.0% | 0.21% | +4.5% |
| Q4 2020 | $705,000 | -41.0% | 135,000 | -45.3% | 0.20% | -53.2% |
| Q3 2020 | $1,194,000 | -32.4% | 246,643 | -27.7% | 0.42% | -38.3% |
| Q2 2020 | $1,766,000 | -11.7% | 340,973 | -25.7% | 0.69% | -85.4% |
| Q1 2020 | $2,001,000 | +223.3% | 458,887 | +197.5% | 4.72% | +909.9% |
| Q4 2019 | $619,000 | +27.4% | 154,255 | +4.2% | 0.47% | -1.3% |
| Q3 2019 | $486,000 | – | 148,092 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |